1. A framework to guide dose & regimen strategy for clinical drug development. (25th September 2021) Authors: Sander, Oliver; Magnusson, Baldur; Ludwig, Inga; Jullion, Astrid; Meille, Christophe; Lorand, Daniel; Bornkamp, Björn; Hinder, Markus; Kovacs, Steven J.; Looby, Michael Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 11(2021) Page Start: 1276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Benchmarking QSP Models Against Simple Models: A Path to Improved Comprehension and Predictive Performance. (22nd August 2018) Authors: Stein, Andrew M.; Looby, Michael Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 7:Number 8(2018) Page Start: 487 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Determination of the pharmacokinetics of glycopyrronium in the lung using a population pharmacokinetic modelling approach. (December 2013) Authors: Bartels, Christian; Looby, Michael; Sechaud, Romain; Kaiser, Guenther Journal: British journal of clinical pharmacology Issue: Volume 76:Number 6(2013:Dec.) Page Start: 868 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Estimands—What they are and why they are important for pharmacometricians. (3rd May 2021) Authors: Akacha, Mouna; Bartels, Christian; Bornkamp, Björn; Bretz, Frank; Coello, Neva; Dumortier, Thomas; Looby, Michael; Sander, Oliver; Schmidli, Heinz; Steimer, Jean‐Louis; Vong, Camille Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 10:Number 4(2021) Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗